Science and Technology Commercialization

Esya Labs Leads Paradigm Shift in Alzheimer’s Using Novel Biomarkers and AI for Revolutionary 360° Perspective of Disease

Esya Lab’s unique organelle-targeted assays facilitate drug discovery for lysosomal storage disorders and numerous other neurocognitive impairments. (Image credit: iStock.com/CIPhotos) Esya Labs is developing tools for the early, precise, and cost-effective detection of neurodegenerative diseases to support drug… Keep reading